top
Search terms
Results 1 - 10 of 14 - ordered by :
Pages: 1 2
Ejhf

Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with ...

European Journal of Heart Failure, Payvar, Saeed, Spertus, John A., Miller, Alan B., Casscells, S. Ward, Pang, Peter S., Zannad, Faiez, Swedberg, Karl, Maggioni, Aldo P., Reid, Kimberly J., ...

Date : 01/12/2013 Item size : 135398 bytes
Ejhf

Introduction Although hypoalbuminaemia occurs in one-third of patients with systolic heart failure (HF)[1] and has been demonstrated to be independently associated with increased risk of death,[2] ...

European Journal of Heart Failure, Liu, Ming, Chan, Chin‐Pang, Yan, Bryan P., Zhang, Qing, Lam, Yat‐Yin, Li, Rui‐Jie, Sanderson, John E., Coats, Andrew J.S., Sun, Jing‐Ping, Yip, Gabriel ...

Date : 01/01/2012 Item size : 160637 bytes
Ehjournal

Methods and results Two investigators independently searched MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials from 1980 to 2011, bibliographies, and contacted primary study ...

European Heart Journal, McAlister, Finlay A.

Date : 01/02/2012 Item size : 279375 bytes
Ehjournal

Abstract Aims On the basis of the JUPITER trial, European health authorities recently approved the use of rosuvastatin to reduce first major cardiovascular events among high' global risk primary ...

European Heart Journal, Koenig, Wolfgang, Ridker, Paul M

Date : 01/01/2011 Item size : 264590 bytes
Ehjournal

The mechanism of action of serelaxin involves activation of the endothelin type B receptor (ETB-receptor) and stimulation of nitric oxide production, that mediate systemic and renal vasodilation and ...

European Heart Journal, Schmieder, Roland E.

Date : 21/10/2013 Item size : 152164 bytes
Ehjournal

None of these drugs improved dyspnoea, worsening heart failure, readmissions to hospital, cardiovascular mortality, or all-cause mortality in AHF patients, mostly during short-term follow-up.1 These ...

European Heart Journal, Hernandez, Adrian V.

Date : 14/02/2014 Item size : 158142 bytes
Ehjournal

Methods and results Two investigators independently searched MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials from 1980 to 2011, bibliographies, and contacted primary study ...

European Heart Journal, McAlister, Finlay A.

Date : 01/02/2012
Ehjournal

The mechanism of action of serelaxin involves activation of the endothelin type B receptor (ETB-receptor) and stimulation of nitric oxide production, that mediate systemic and renal vasodilation and ...

European Heart Journal, Schmieder, Roland E.

Date : 21/10/2013 Item size : 144559 bytes
Ehjournal

Abstract Aims On the basis of the JUPITER trial, European health authorities recently approved the use of rosuvastatin to reduce first major cardiovascular events among high' global risk primary ...

European Heart Journal, Koenig, Wolfgang, Ridker, Paul M

Date : 01/01/2011
Ehjournal

None of these drugs improved dyspnoea, worsening heart failure, readmissions to hospital, cardiovascular mortality, or all-cause mortality in AHF patients, mostly during short-term follow-up.1 These ...

European Heart Journal, Hernandez, Adrian V.

Date : 14/02/2014